EurekaMag.com logo
+ Translate

Human milk glycosaminoglycans inhibit HIV glycoprotein gp120 binding to its host cell CD4 receptor


, : Human milk glycosaminoglycans inhibit HIV glycoprotein gp120 binding to its host cell CD4 receptor. Journal of Nutrition 125(3): 419-424

The binding of the HIV envelope glycoprotein, gp120, to its host cell receptor, CD4, is inhibited in a solid phase assay by a glycosaminoglycan of human milk; this binding is the essential first step in HIV infectivity. The human milk glycosaminoglycans were identified in this study. Pooled, fractionated human milk contained dermatan sulfate, heparin, heparan sulfate, and chondroitin sulfate. The ability of this glycosaminoglycan fraction to inhibit binding was unaffected by digestion with lytic enzymes specific for heparin, heparan sulfate and dermatan sulfate, but was lost when the milk fraction was treated with lytic enzymes specific for chondroitin sulfate. Furthermore, a purified milk fraction with high specific inhibitory activity contained chondroitin sulfate but not other glycosaminoglycans. This indicates that the ability of human milk to inhibit gp120 binding to CD4 may be attributed to chondroitin sulfate or to a chondroitin sulfate-like moiety rather than to other components of human milk. We speculate that this human milk glycosaminoglycan could limit the rate of postnatal vertical transmission of HIV in breast-fed infants of HIV-infected mothers.

(PDF 0-2 workdays service)

Accession: 003162986

PMID: 7876916

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Tait Kamradt, A.; Petitpas, J.; Clancy, J.; Mcguirk, P.; Subashi, T.; Watts, P.; Wondrack, L., 1993: Assays to detect AIDS receptor antagonists, compounds that inhibit the binding of the HIV-1 surface glycoprotein, gp120, to the CD4 receptor in human T-lymphocytes. Abstracts of the General Meeting of the American Society for Microbiology 93(0): 436

Clancy, J.; Tait-Kamradt, A.; Petitpas, J.; Manousos, M.; McGuirk, P.R.; Subashi, T.; Watts, P.; Wondrack, L., 1994: Assays to detect and characterize human immunodeficiency virus type 1 (HIV-1) receptor antagonists, compounds that inhibit binding of the HIV-1 surface glycoprotein, gp120, to the CD4 receptor on human T lymphocytes. Human immunodeficiency virus type 1 infects human helper T lymphocytes by an interaction between gp120, the viral coat protein, and the T-cell receptor CD4. Two microtiter-based immunoassays, an enzyme-linked immunosorbent assay (ELISA) and a part...

Yahi, N.; Sabatier, J.M.; Nickel, P.; Mabrouk, K.; Gonzalez-Scarano, F.; Fantini, J., 1994: Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells. The infection of human colonic epithelial cells HT-29 by human immunodeficiency virus type 1 (HrV-1) occurs independently of CD4, the main HIV-1 receptor expressed on lymphocytes and macrophages. Recent studies from our group have shown that HT-29...

Newburg D.S.; Ampofo S.; Linhardt R.J.; Yolken R.H., 1992: Human milk glycosaminoglycan inhibits binding of the hiv glycoprotein gp 120 to its host receptor cd4. Pediatric Research 31(4 PART 2): 172A

Raja, A.; Venturi, M.; Kwong, P.; Sodroski, J., 2002: CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5. The human immunodeficiency virus type 1 (HIV-1) gp120 exterior glycoprotein is conformationally flexible. Upon binding the host cell receptor, CD4, gp120 assumes a conformation that is able to bind the chemokine receptors CCR5 or CXCR4, which act...

Cefai D.; Debre P.; Kaczorek M.; Idziorek T.; Autran B.; Bismuth G., 1990: Hiv 1 glycoproteins gp120 and gp120 specifically inhibit the cd3 t cell antigen receptor phosphoinositide transduction pathway. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Fa78

Newburg, D.S.; Yolken, R.H., 1991: Characterization of a human milk factor that inhibits binding of HIV GP120 to its CD4 receptor. 34 milk samples from women in the USA (Maryland and Massachusetts) and Haiti all strongly inhibited the binding of the human immunodeficiency virus (HIV) envelope glycoprotein gp120 to the host cell receptor CD4. This inhibitory effect, which was...

Lekkerkerker, A.N.; Ludwig, I.S.; van Vliet, S.J.; van Kooyk, Y.; Geijtenbeek, T.B.H., 2004: Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120. The interaction of DC-SIGN with gp120 provides an attractive target for intervention of HIV-1 transmission. Here, we have investigated the potency of gp120 antibodies to inhibit the DC-SIGN-gp120 interaction. We demonstrate that although the V3 lo...

Chatila, T.A.; Morio, T.; Geha, R.S., 1993: Inhibition of T cell receptor/CD3-mediated activation of p59-fyn and p56-lck by human immunodeficiency virus glycoprotein gp120. Journal of Immunology 150(8 PART 2): 101A

Matthews, T.J.; Weinhold, K.J.; Lyerly, H.K.; Langlois, A.J.; Wigzell, H.; Bolognesi, D.P., 1987: Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Interactions between retroviruses associated with acquired immunodeficiency syndrome and their receptors on lymphocytes represent the initial steps in the process of infection and are also involved in multinucleated giant cell formation, which is...